Cystic Fibrosis Foundation Therapeutics Inc is located in Bethesda, MD. The organization was established in 2000. According to its NTEE Classification (U50) the organization is classified as: Biological & Life Sciences, under the broad grouping of Science & Technology and related organizations. As of 12/2022, Cystic Fibrosis Foundation Therapeutics Inc employed 61 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Cystic Fibrosis Foundation Therapeutics Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
Form
990EZ
Mission & Program ActivityExcerpts From the 990EZ Filing
TAX YEAR
2022
Describe the Organization's Program Activity:
Part 3
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS IS OPERATED EXCLUSIVELY FOR THE BENEFIT OF, TO PERFORM THE FUNCTIONS OF, AND TO CARRY OUT THE PURPOSES OF THE CYSTIC FIBROSIS FOUNDATION (EIN 13-1930701), ITS SUPPORTED ORGANIZATION.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Michael P Boyle MD President/director | 1 | $0 | |
Irena Barisic Treasurer/director | 1 | $0 | |
Michael Cavadel Secretary/director | 1 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Vertex Pharmaceuticals Inc Contracted Research | 12/30/17 | $12,500,000 |
Genzyme Corporation Contracted Research | 12/30/17 | $9,330,280 |
Pfizer Inc Contracted Research | 12/30/17 | $2,120,889 |
Celtaxsys Inc Contracted Research | 12/30/17 | $2,073,333 |
Spyryx Biosciences Inc Contracted Research | 12/30/17 | $2,023,217 |
Statement of Revenue | |
---|---|
Total Revenue from Contributions, Gifts, Grants & Similar | $0 |
Total Program Service Revenue | $0 |
Membership dues | $0 |
Investment income | $0 |
Gain or Loss | $0 |
Net Income from Gaming & Fundraising | $0 |
Other Revenue | $0 |
Total Revenue | $0 |
Statement of Expenses | |
---|---|
Grants and similar amounts paid | $0 |
Benefits paid to or for members | $0 |
Salaries, other compensation, and employee benefits | $0 |
Professional fees and other payments to independent contractors | $0 |
Occupancy, rent, utilities, and maintenance | $0 |
Printing, publications, postage, and shipping | $0 |
Other expenses | $0 |
Total expenses | $0 |
Balance Sheet | |
---|---|
Cash, savings, and investments | $0 |
Other assets | $0 |
Total assets | $0 |
Total liabilities | $0 |
Net assets or fund balances | $0 |
Over the last fiscal year, Cystic Fibrosis Foundation Therapeutics Inc has awarded $61,754,672 in support to 186 organizations.
Grant Recipient | Amount |
---|---|
CHILDREN'S HOSPITAL CORPORATION (BOSTON CHILDREN'S PURPOSE: ACADEMIC ADVISORY AWARD | $48,295 |
ARIZONA BOARD OF REGENTS UNIVERSITY OF ARIZONA PURPOSE: ADHERENCE | $30,240 |
BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UN PURPOSE: ADHERENCE | $30,240 |
CHILDREN'S HOSPITAL CORPORATION (BOSTON CHILDREN'S PURPOSE: ADHERENCE | $2,679,083 |
CHILDREN'S HOSPITAL MEDICAL CENTER (CINCINNATI CHI PURPOSE: ADHERENCE | $30,240 |
NATIONAL JEWISH MEDICAL AND RESEARCH CENTER PURPOSE: ADHERENCE | $30,073 |